HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The problem with cyclophosphamide, doxorubicin, vincristine and prednisone for the treatment of peripheral T-cell lymphoma.

AuthorsRoopesh Kansara, Kerry J Savage
JournalLeukemia & lymphoma (Leuk Lymphoma) Vol. 55 Issue 4 Pg. 727-9 (Apr 2014) ISSN: 1029-2403 [Electronic] United States
PMID24295133 (Publication Type: Journal Article, Comment)
Topics
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Female
  • Humans
  • Killer Cells, Natural (pathology)
  • Lymphoma, T-Cell, Peripheral (drug therapy)
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: